You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《業績預告》麗珠醫藥(01513.HK)料上半年盈利升30%至40%
阿思達克 07-14 16:39
麗珠醫藥(01513.HK)發業績預告,預期截至6月底止上半年,盈利介乎9.61億至10.35億元人民幣,按年升30%至40%。基本每股收益為1.02元至1.1元人民幣。

公司指,主因出售江蘇尼科醫療器械有限公司股權增加了純利8,523.99萬元,上半年受新型冠狀病毒肺炎疫情影響,公司處方藥相關產品銷售雖未達預期,但由於抗病毒顆粒及注射用艾普拉唑鈉同比去年上半年大幅增長,加之新型冠狀病毒抗體檢測試劑產品實現新增銷售,為公司整體業績增長提供了重要支持。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account